Suppr超能文献

急性A型主动脉夹层合并肠系膜灌注不良管理的系统评价

Systematic Review of the Management of Acute Type A Aortic Dissection with Mesenteric Malperfusion.

作者信息

Wang Changtian, Wu Haiwei, Xi Zhilong, Liu Qiang, Sun Lei, Zhang Lei

机构信息

Department of Cardiovascular Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, 210002 Nanjing, China.

出版信息

Rev Cardiovasc Med. 2023 Apr 24;24(5):127. doi: 10.31083/j.rcm2405127. eCollection 2023 May.

Abstract

BACKGROUND

Surgical treatment strategy for acute type A aortic dissection (aTAAD) with mesenteric malperfusion (MMP) is quite challenging as it is often associated with poor patient outcomes, and optimal management strategies remain controversial.

METHODS

We conducted MEDLINE and EMBASE database searches up to December 31, 2021 for studies on aTAAD with MMP. Data on study design, patient demographics, patient management strategy, mortality, complications, and follow-up were extracted, analyzed, and investigated.

RESULTS

Our literature search identified 941 potentially relevant studies, of which 19 were deemed eligible for this study. A total of 352 patients, mean age: 58.4 11.9 years, diagnosed with aTAAD complicated with MMP were included with an overall prevalence of 4%. Patients for which MMP was observed preoperatively were also included in this analysis. The overall in-hospital mortality amongst these patients was 43.5%, and bowel necrosis and/or multiorgan failure were the major causes of death. Four management strategies for first-line treatment were recognized and these included central aortic repair (191, 54.3%), reperfusion of superior mesenteric artery (SMA) (121, 34.3%), exclusively endo-intervention (11, 3.1%), and exclusively medical intervention (29, 8.2%). These various first-line strategies showed mortality rates of 40.3%, 33.9%, 72.7% and 93.1%, respectively. There was no significant difference in the mortality rate between central aortic repair and reperfusion of SMA as first-line therapies ( = 1.302, = 0.254). When compared with central aortic repair and reperfusion of SMA, exclusively medical care exhibited a significantly greater mortality rate ( 0.01).

CONCLUSIONS

aTAAD complicated with MMP is a rare complication that carries a high mortality rate. Central aortic repair and reperfusion of SMA as first-line treatment strategies appear to be associated with better outcomes compared with exclusively endo-intervention and medical care. Clinical decisions may have introduced biases as no differences were indicated in regards to the way patients were being prioritized for the central aortic repair versus reperfusion of SMA. In regards to variable clinical features and pathology of aTAAD complicated with MMP, an individualized approach is recommended.

摘要

背景

急性A型主动脉夹层(aTAAD)合并肠系膜灌注不良(MMP)的外科治疗策略极具挑战性,因为它常常与患者的不良预后相关,且最佳管理策略仍存在争议。

方法

我们在截至2021年12月31日的MEDLINE和EMBASE数据库中检索了关于aTAAD合并MMP的研究。提取、分析并研究了有关研究设计、患者人口统计学特征、患者管理策略、死亡率、并发症及随访的数据。

结果

我们的文献检索共识别出941项潜在相关研究,其中19项被认为符合本研究的条件。总共纳入了352例诊断为aTAAD合并MMP的患者,平均年龄为58.4±11.9岁,总体患病率为4%。术前观察到MMP的患者也纳入了本分析。这些患者的总体院内死亡率为43.5%,肠坏死和/或多器官功能衰竭是主要死亡原因。确认了四种一线治疗管理策略,包括主动脉中央修复(191例,54.3%)、肠系膜上动脉(SMA)再灌注(121例,34.3%)、单纯腔内干预(11例,3.1%)和单纯药物干预(29例,8.2%)。这些不同的一线策略的死亡率分别为40.3%、33.9%、72.7%和93.1%。主动脉中央修复和SMA再灌注作为一线治疗的死亡率之间无显著差异(P = 1.302,P = 0.254)。与主动脉中央修复和SMA再灌注相比,单纯药物治疗的死亡率显著更高(P < 0.01)。

结论

aTAAD合并MMP是一种罕见的并发症,死亡率很高。与单纯腔内干预和药物治疗相比,主动脉中央修复和SMA再灌注作为一线治疗策略似乎与更好的预后相关。由于在主动脉中央修复与SMA再灌注的患者优先顺序方面未显示出差异,临床决策可能引入了偏差。对于aTAAD合并MMP的可变临床特征和病理情况,建议采用个体化方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c314/11273023/e3633aeb9182/2153-8174-24-5-127-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验